Skip to content
healthcare.dev

NAVITRUX

NDC 83831-153, fosaprepitant, injection, powder, lyophilized, for solution, from AVYXA Pharma, LLC.

Product NDC
83831-153
Status
Listed
Labeler
AVYXA Pharma, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA220436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83831-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FOSAPREPITANT DIMEGLUMINE150 mg/5mL

Pharmacologic classes

Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
83831-153-01838310153011 VIAL in 1 CARTON (83831-153-01) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a41b7c3a-1376-43a7-b5b9-6ba2eba1e169

Use it

Look up 83831-153 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83831-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83831-153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.